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Abstract 
Adult mammals undergo minimal regeneration following cardiac injury, which 
severely compromises cardiac function and contributes to the ongoing burden of 
heart failure. In contrast, the mammalian heart retains a transient capacity for 
cardiac regeneration during fetal and early neonatal life. Recent studies have 
established the importance of several evolutionarily conserved mechanisms for 
heart regeneration in lower vertebrates and neonatal mammals including 
induction of cardiomyocyte proliferation, epicardial cell activation, angiogenesis, 
extracellular matrix deposition and immune cell infiltration. In this review, we 
provide an up-to-date account of the molecular and cellular basis for cardiac 
regeneration in lower vertebrates and neonatal mammals. The historical context 
for these recent findings and their ramifications for the future development of 
cardiac regenerative therapies are also discussed.  
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1. Introduction 
Since the first systematic studies of organ regeneration in the 18th century, 
countless biologists have interrogated the mechanisms by which animals replace 
lost body parts. Regenerative phenomena have since been described in hydra, 
crustaceans, worms, fruit flies, frogs, salamanders, zebrafish, rodents and 
humans. Organ regeneration involves an astonishing diversity of cellular 
mechanisms including recruitment and activation of stem cells, as well as de-
differentiation, trans-differentiation and proliferation of differentiated cell types (1). 
Despite a rich history of regeneration research spanning several hundreds of 
years, the first descriptions of cardiac regeneration in lower vertebrates were only 
reported within the last few decades (2-4). The paucity of early studies on heart 
regeneration, even in highly regenerative lower vertebrates, is likely a 
consequence of the conceptual constraints that were imposed by the long 
standing dogma that the adult heart was terminally differentiated and lacked any 
appreciable regenerative capacity, a view that underpinned mammalian cardiac 
biology for over a century (5).  
 
It is not unreasonable that the heart has been traditionally viewed as a non-
regenerative organ. In response to cardiac injury, such as that induced by a 
myocardial infarction, the adult mammalian heart fails to replace the vast majority 
of cardiomyocytes that are lost or damaged. In the absence of a robust 
regenerative response, the heart substitutes the lost cardiomyocytes with scar 
tissue, which contributes to the contractile demise of the organ and ultimately 
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leads to heart failure. However, the traditional view of the heart as a terminally 
differentiated organ without any capacity for cardiomyocyte renewal has been 
emphatically refuted in recent years by a growing number of studies in humans 
(6-8) and other mammals (9-11). The underlying mechanisms for cardiomyocyte 
regeneration remain highly controversial but the degree of cell turnover is clearly 
insufficient to replace the large number of cardiomyocytes (up to 1 billion in 
humans) that are lost following a major ischemic event. As such, regeneration of 
myocardial tissue following injury remains a major goal of contemporary research 
in the field. A number of cardiac regenerative strategies have been proposed 
including cell replacement therapies, activation of endogenous progenitor cell 
populations, cardiomyocyte cell cycle re-entry and, most recently, direct lineage 
reprogramming. However, while all of these approaches offer hope to heart 
failure patients, they all currently suffer from inherent limitations and translational 
barriers (12). An alternative and complimentary approach is to explore, and 
ultimately attempt to recapitulate, innate mechanisms of cardiac regeneration 
such as those that have evolved in highly regenerative organisms, such as the 
zebrafish, as well as those that exist during privileged developmental windows in 
mammals. In this review, we provide an overview of cardiac regenerative 
phenomena in lower vertebrates and neonatal mammals, with a particular 
emphasis on recent advances that are beginning to shed light on the underlying 
molecular and cellular mechanisms that govern cardiac regenerative capacity 
during mammalian development. 
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2. Cardiac regeneration in lower vertebrates 
In the 1960’s, scientists working in the former Soviet Union conducted the first 
studies of cardiac regeneration in amphibians (3, 4, 13). Mitotic cells were 
observed following cardiac injury in lower vertebrates, including adult frogs, 
newts and axolotls (3, 4, 13, 14). Later transmission electron microscopy studies 
following resection of the ventricular apex of adult newts confirmed the presence 
of mitotic cardiomyocytes in the wounded area but failed to document complete 
regeneration of the myocardium, which was characterized by the presence of 
connective scar tissue following injury (2, 15). Collectively, these early studies 
suggested that although amphibians are capable of inducing cardiomyocyte 
proliferation following injury, the regenerative response is incomplete. However, a 
more recent study by Witman and colleagues has provided evidence for 
complete regeneration of the adult newt heart following resection of a small 
region of heart tissue at the base of the cardiac ventricles (16). In contrast to 
earlier studies where the entire ventricular apex was removed, Witman et al. 
induced a mode of injury that does not breach the ventricular cavity (Figure 1). 
Resection of the base of the cardiac ventricles in adult newts was associated 
with gradual restoration of the myocardial tissue over a period of 60 days (16). 
Although these results were at odds with earlier reports of a much more limited 
regenerative potential of the adult newt heart, the earlier studies may have been 
prematurely terminated for histological analyses, prior to completion of the 
reverse remodeling phase, which must take place in order for the heart to regain 
its normal morphological appearance (16). In addition, the anatomical location of 
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the injury site near the atrioventricular boundary could be important and may 
reflect a differential regenerative capacity of cardiomyocytes or progenitor cells 
located in this region compared with the apex of the adult newt heart.  
 
In contrast to the variable descriptions of heart regeneration in amphibians, 
zebrafish can regenerate following multiple types of cardiac injury including 
ventricular resection, cryoinjury and genetic cardiomyocyte ablation (17-19). 
Cardiac injury induces a marked increase in cardiomyocyte proliferation in the 
adult zebrafish heart and genetic lineage tracing experiments suggest that the 
vast majority of regenerated cardiomyocytes are derived from pre-existing 
cardiomyocytes rather than from a stem cell population (20, 21). Regenerative 
mechanisms in different adult zebrafish cardiac injury models have been 
described in detail elsewhere (22) and are summarized in Figure 1. 
 
3. Cardiac regeneration in mammals – privileged windows of development 
Since Spallanzani’s seminal treatise on the age-dependency of tail regeneration 
in tadpoles and salamanders almost 250 years ago (23), the relationship 
between development and regeneration has received much attention. While the 
adult human heart does not undergo any appreciable regeneration following 
injury, the possibility of cardiac regeneration in children and infants has been 
considered for almost a century. The earliest reports of cardiac regeneration in 
children involved careful analyses of post-mortem histological specimens from 
children with diphtheria (24, 25). The presence of mitotic figures and splitting of 
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myocardial fibers in such cases led to the suggestion that cardiac regeneration 
might be possible during early developmental stages (24). There is even some 
evidence for cardiac regeneration in children undergoing corrective cardiac 
surgery for congenital heart malformations (26). However, direct experimental 
evidence for this developmental phenomenon has only been provided very 
recently in different mammalian model systems.   
 
The heart undergoes rapid growth and remodeling during embryogenesis. The 
heart also retains significant growth plasticity during embryonic and fetal life in 
the face of different environmental insults including nutrient deprivation, 
variations in litter size, changes in blood flow, as well as mechanical and volume 
loading (27). Such plasticity is presumably lost during postnatal life, as genetic 
and environmental insults that lead to excessive myocyte loss during early 
development are frequently associated with maladaptive compensatory 
remodeling and cardiac pathologies in adulthood (28-30). The most compelling 
evidence for cardiac regeneration during embryogenesis comes from genetic 
studies in mice.  Similar to genetic cardiomyocyte ablation studies in zebrafish, 
Drenckhahn et al. have provided evidence for compensatory growth of healthy 
cardiac cells in diseased embryonic mouse hearts (31). In response to 
heterozygous deletion of the X-linked Holocytochrome c synthase (Hccs) gene, 
encoding an enzyme required for mitochondrial respiration, heterozygous female 
embryos were able to compensate for a 50% deficiency in cardiac cells. 
Interestingly, the remaining healthy cells gradually replaced the diseased cells 
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over time, suggesting that the embryonic heart has significant regenerative 
capacity. The embryonic regenerative response in embryonic mice was 
associated with robust induction of cardiomyocyte proliferation in healthy cells, 
which likely underlies the enhanced regenerative capacity at early developmental 
stages prior to the onset of postnatal mitotic arrest in mammals (31). 
Interestingly, a significant proportion of Hccs-deficient cells were still present in 
the ventricles of neonatal mice (~30% in the interventricular septum), suggesting 
that this innate cardiac regenerative capacity might extend into the early 
postnatal period (31).  
 
In order to determine whether the neonatal mammalian heart harbors any 
significant regenerative capacity, we recently developed a surgical model of 
cardiac injury in 1-day-old neonatal mice (Figure 1) (32). Following amputation of 
a portion of the ventricular apex comprising approximately 15% of the ventricle, 
neonatal mice mounted a regenerative response that restored the lost myocardial 
tissue over a period of 3 weeks. Apical resection injury was associated with a 
series of cellular events highly reminiscent of cardiac regeneration in lower 
vertebrates, including formation of a blood clot, recruitment of inflammatory cells 
to the site of injury, epicardial cell activation, early extracellular matrix deposition, 
cardiomyocyte proliferation and restoration of normal cardiac function (32). The 
ability to efficiently regenerate heart muscle following amputation was lost by 
postnatal day 7, coinciding with the developmental window when rodent 
cardiomyocytes begin to lose their proliferative potential (33, 34). Genetic lineage 
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tracing studies confirmed that the vast majority of regenerated cardiomyocytes in 
1-day-old mice were derived from pre-existing cardiomyocytes through cell 
proliferation (32). However, a minor contribution of non-myocytes to neonatal 
cardiac regeneration could not be excluded due to limitations in the 
cardiomyocyte labeling efficiency that could be achieved using the tamoxifen-
inducible Myh6-MerCreMer transgenic system (~70-80% in P1 mice) (32).  
 
More recent studies by our group and others suggest that 1-day-old neonatal 
mice are also capable of undergoing cardiac regeneration following myocardial 
infarction, which is the leading cause of heart failure in humans (35, 36). 
Myocardial ischemia was induced by permanent ligation of the left anterior 
descending coronary artery (LAD) in 1-day-old mice (Figure 1). LAD ligation was 
associated with a marked reduction in myocardial viability and a dramatic decline 
in cardiac function at day 3 following infarction (36). However, within 3 weeks, 
neonatal mice were able to launch a regenerative response that restored 95% of 
the infarcted myocardium and returned cardiac function to normal. Importantly, 
cardiac function was still unperturbed at 9 months of age, suggesting that the 
neonatal regenerative response can sustain cardiac function for several months 
following injury (36). Similar to cryocauterization in the zebrafish, neonatal 
infarction was associated with early collagen deposition, which later regressed 
and became marginalized to the periphery of the tissue. Little to no fibrosis was 
detectable at 3 weeks following infarction, with the exception of a small region of 
tissue immediately adjacent to the ligature (36). Histological and genetic lineage 
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tracing studies confirmed that the majority of regenerated cardiomyocytes were 
derived from pre-existing cardiomyocytes through cell proliferation, similar to 
earlier studies in zebrafish, as well as following apical resection in neonatal mice 
(35, 36). In addition, a robust angiogenic response was associated with heart 
regeneration in neonatal mice (36). Corrosion casting of the coronary vasculature 
revealed large collateral vessels in the newly regenerated anterior wall of the left 
ventricle that had originated from the right side of the heart. Consistent with 
earlier studies using the apical resection model, 7- and 14-day-old mice failed to 
undergo cardiac regeneration following myocardial infarction, suggesting that 
cardiac regenerative capacity was lost within the first two weeks after birth in 
rodents (36). These observations in 7-day-old mice were strikingly concordant 
with earlier studies by Robledo in the 1950’s, which noted an incomplete cardiac 
regenerative response in 4-7 day-old rats following myocardial burn injury using a 
heated wire (37). Collectively, these findings suggest that the neonatal heart has 
a robust capacity for cardiac regeneration following multiple forms of tissue 
damage, including myocardial infarction, but this regenerative potential is rapidly 
silenced after birth. 
 
Adding to the growing repertoire of available cardiac injury models for neonatal 
mice, Jesty et al. recently reported on the cardiomyogenic potential of neonatal 
mice following cryoinjury (38). In response to cryoinfarction at 1-3 days-of-age, 
neonatal mice underwent a marked cardiomyogenic response and regenerated a 
large proportion of the infarcted tissue over a period of 94 days. Consistent with 
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observations in the apical resection and myocardial infarction models, neonatal 
cryoinjury was associated with robust induction of cardiomyocyte proliferation 
throughout the heart (Figure 1). However, in addition to cardiomyocyte 
proliferation, a contribution of c-kit+ cardiac progenitor cells to cardiomyogenesis 
and angiogenesis in the neonate was also noted, suggesting that a pool of 
cardiac progenitor cells may be capable of supporting cardiac regeneration in 
neonatal mice (38). Although significant scar regression was observed in this 
model, it should be noted that regeneration was not complete at 94 days 
following cryoinjury. In contrast, a very recent paper by Strungs et al. has 
reported complete regeneration of the neonatal heart following cryoinjury at P1 
and this regenerative potential is lost by P7, similar to previous findings in apical 
resection and myocardial infarction models (39). However, given that neither 
Jesty et al. nor Strungs et al. reported the size or reproducibility of neonatal 
cryoinfarcts, it is unclear whether the lack of complete regeneration in the Jesty 
et al. study is due to a larger infarct size or the degree of transmurality of the 
infarcts. Given that cryoablation of only 25% of the zebrafish heart is also 
associated with a much more protracted regenerative response (17), it will be 
important to assess the regenerative capacity of the neonatal mouse heart 
following small, large, superficial and transmural infarcts in the future in order to 
determine the physiological limits of neonatal heart regeneration. 
 
Although studies in rodents offer a powerful experimental approach to the 
developmental regulation of cardiac regeneration, it is well known that both the 
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timing of cardiac maturation and the cardiovascular physiology of the rodent 
heart are different to large animals, such as humans (40). Therefore, systematic 
studies of heart regeneration at different developmental stages in large animal 
models are important. While the literature in this field is sparse, it has been 
reported that fetal sheep can undergo regenerative healing following myocardial 
infarction during early gestation (41, 42). Further studies are required to 
determine the precise timing and cellular mechanisms underlying regenerative 
arrest in large animal models, including whether this capacity extends into the 
immediate postnatal period. 
 
4. Cardiomyocyte proliferation contributes to cardiomyocyte replenishment 
during aging and following injury 
An underlying feature of cardiac regeneration in lower vertebrates and neonatal 
mice is the robust cardiomyocyte proliferative response (15, 18, 32, 36), which is 
absent in non-regenerative adult mammals. In contrast to zebrafish and newt 
cardiomyocytes, which remain predominantly mononucleated and retain 
proliferative potential throughout life, most mammalian cardiomyocytes 
permanently withdraw from the cell cycle before adulthood (22). In rodents, 
cardiomyocytes undergo a final round of DNA synthesis and karyokinesis in the 
absence of cytokinesis, which results in the binucleation of the vast majority (90-
95%) of cardiomyocytes by postnatal day 14 (33, 43, 44). In contrast, 
binucleation in large mammals, such as sheep, is typically completed before birth 
(45). Interestingly, the proportion of binucleated cardiomyocytes is much lower in 
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humans than other mammals (~30-40%)(46). Although the proportion of 
binucleated cardiomyocytes does not change after birth in humans, there is a 
significant increase in the number of polyploid cardiomyocytes from birth (~5%) 
to 40 years of age (~60%)(46). Indeed, a recent study by Mollova et al. indicates 
that cardiomyocytes continue to proliferate, albeit at a low rate, during the first 20 
years of human life (46), suggesting that the “proliferative window” for human 
cardiomyocytes might extend well into childhood and adolescence. 
 
Over the last decade, a number of studies have proposed that the adult 
mammalian heart is not a terminally differentiated organ and is capable of turning 
over cardiomyocytes throughout life and following injury (47). The most 
compelling evidence for this radical concept comes from radiocarbon dating 
experiments of nuclear DNA from heart samples that were exposed to nuclear 
fallout during weapons testing during the Cold War. These studies revealed that 
human cardiomyocytes turn over at a low rate of about 1% per year, which 
declines to 0.5% per year after the age of 50 (6). The cellular source of these 
regenerated cardiomyocytes in humans remains controversial, but a recent study 
in mice suggests that cardimoyocyte proliferation is most likely the dominant 
cellular mechanism (11). Therefore, cardiomyocyte proliferation appears to be 
the primary natural mechanism for cardiomyocyte replenishment in highly 
regenerative organisms such as zebrafish and neonatal mice, as well as in less 
regenerative adult mammals. As such, understanding the mechanisms that 
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govern cardiomyocyte proliferation during development and regeneration is 
paramount. 
 
5. Cardiomyocyte proliferative signaling during neonatal heart development 
and regeneration 
As with many regenerative processes, cardiac regeneration in adult zebrafish 
involves the re-engagement of a number of growth factor signaling pathways that 
guide embryonic heart development, including the Igf, RA, Fgf and Notch 
signaling pathways (Figure 2) (48-51). However, in contrast to the capacity of 
these growth factors to stimulate myocardial proliferation during embryogenesis 
and early neonatal life in mammals, adult mammalian cardiomyocytes do not 
readily re-enter the cell cycle in response to similar developmental cues (52, 53). 
Even in response to mitogens that are associated with some degree of adult 
cardiomyocyte proliferation, such as neuregulin, periostin, FGF in combination 
with a p38 MAPK inhibitor or inhibition of glycogen synthase kinase 3, only a 
very low percentage of adult cardiomyocytes re-enter the cell cycle and complete 
cytokinesis, and this effect is thought to be restricted to the mononucleated 
subset of cardiomyocytes in rodents (54-58). Interestingly, even in the highly 
proliferative adult newt heart, only ~30% of binucleated cardiomyocytes were 
able to undergo cytokinesis, suggesting that binucleation is a major barrier to 
cardiomyocyte mitotic progression (59). As such, recent attention has focused on 
unraveling the underlying molecular events that silence the genetic networks 
required for cardiomyocyte proliferation during neonatal life. 
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5.1. Chromatin remodeling maintains the post-mitotic cardiac phenotype 
Genes are packed in chromatin, which is remodeled into active (euchromatin) 
and inactive (heterochromatin) states by covalent modifications of DNA and 
histones. The three primary mechanisms for chromatin-dependent regulation of 
gene expression are: DNA methylation, ATP-dependent chromatin remodeling, 
and covalent histone modifications, such as acetylation and methylation. A recent 
study has demonstrated that heterochromatin (associated with gene silencing) 
accumulates during postnatal cardiomyocyte maturation and that this is 
associated with enrichment of the gene-silencing epigenetic mark H3K9me3 at 
the promoters of cell cycle genes (60). Interestingly, both in vivo and in vitro loss-
of-function studies indicated that the recruitment of heterochromatin protein 1-
gamma (HP1- to cell cycle gene promoters resulted in their incorporation into 
heterochromatin and irreversible silencing in adult cardiomyocytes in an 
Rb/p130-dependent manner (60). Although the significance of these findings for 
cardiac regeneration following ischemic injury is currently unclear, these results 
indicate that alterations in chromatin structure are associated with the 
maintenance of the post-mitotic cardiomyocyte phenotype in mammals. 
 
Evidence for a role of epigenetic modifiers in the regulation of cardiomyocyte 
proliferation also comes from a number of genetic gain- and loss-of-function 
studies in the mouse. Deletion of the histone deacteylases, Hdac1 and Hdac2, in 
cardiomyocytes results in neonatal lethality within 2 weeks after birth due to 
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cardiac arrhythmias and dilated cardiomyopathy (61). Combined loss of Hdac2 
and Hopx is also associated with increased cardiomyocyte proliferation and 
myocardial thickening and this effect is mediated through deacetylation of Gata4, 
which is a transcription factor that is required for cardiomyocyte expansion during 
embryogenesis (62). Hdac3 is also involved in the regulation of cardiomyocyte 
proliferative capacity, as over-expression of Hdac3 in cardiomyocytes stimulates 
proliferation by suppressing the expression of a number of cyclin-dependent 
kinase inhibitors (63). In addition, histone methyltransferases and demethylases 
have been implicated in the regulation of cardiomyocyte mitosis during 
embryogenesis, with Jumonji and Smyd1 mutants both displaying severe 
ventricular hypoplasia phenotypes (64, 65). Similarly, genetic deletion of the 
ATP-dependent chromatin-remodeling factor, Brahma-related gene 1 (Brg1), is 
associated with myocardial proliferative defects in mice (66). Taken together, 
these findings support the contention that epigenetic events underlie the 
maintenance of the proliferative state and expression of fetal genes during 
cardiac development. Future studies will be required to determine the relative 
importance of these epigenetic events for postnatal silencing of cardiac 
regenerative potential in mammals. 
 
5.2. Regulation of cardiomyocyte proliferation and cardiac regeneration by 
microRNAs 
MiRNAs are now recognized as central modulators of cardiac development and 
disease. Given their capacity to suppress large collections of proteins 
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participating in common signaling pathways, miRNAs could be engaged as 
important biological and therapeutic regulators of cardiomyocyte proliferation 
(67). In an attempt to identify miRNAs involved in postnatal cardiomyocyte mitotic 
arrest, microarrays were used to profile miRNAs in 1- and 10-day-old mouse 
hearts (68). One of the most highly up-regulated miRNAs during this 
developmental window was miR-195, a member of the miR-15 family, which was 
previously identified as a critical tumor suppressor miRNA (69, 70). Gain- and 
loss-of-function studies in the mouse subsequently validated the miR-15 family 
as an important regulator of postnatal cardiomyocyte mitotic arrest. Over-
expression of miR-195 in developing cardiomyocytes was associated with 
premature cell cycle arrest and a subset of transgenic mice displayed congenital 
abnormalities including ventricular septal defects (68). Following myocardial 
infarction at P1, miR-195 transgenic mice also failed to regenerate and formed 
large fibrotic scars with an associated decline in cardiac contractile function (36). 
In contrast, postnatal inhibition of the entire miR-15 family using locked nucleic 
acid (LNA)-modified antimiRs prolonged the proliferative capacity of neonatal 
cardiomyocytes beyond the normal window of postnatal cell cycle arrest (68). 
Furthermore, postnatal inhibition of the miR-15 family induced cardiomyocyte 
proliferation and improved cardiac function in adult mice subjected to ischemia-
reperfusion injury (36). Importantly, acute inhibition of the miR-15 family in small 
and large animal models is also associated with an improvement in cardiac 
function following ischemia-reperfusion injury (71), but whether this effect is due 
in part to cardiomyocyte cell cycle re-entry is currently unclear. Consistent with 
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the effects of the miR-15 family on cardiomyocyte proliferation, a number of cell 
cycle genes, including checkpoint kinase 1 (Chek1), have been identified as 
important downstream target genes (68). Taken together, these results suggest 
that the miR-15 family is an important regulator of cardiomyocyte mitosis and 
cardiac regenerative capacity during the neonatal period. 
 
Another group of miRNAs that is critical for postnatal cardiomyocyte mitotic arrest 
is the miR-17~92 cluster. The miR-17~92 cluster was originally identified as a 
human oncogene and genetic loss-of-function studies in mice had previously 
revealed important functions for this miRNA cluster during embryonic heart 
development (72, 73). A recent study has also assessed the effects of miR-
17~92 gain- and loss-of-function on cardiomyocyte proliferation during 
embryogenesis and postnatal life. Cardiomyocyte-specific deletion of the miR-
17~92 cluster demonstrated an essential role during cardiomyocyte proliferation 
in embryonic and postnatal hearts (74). Moreover, transgenic over-expression of 
miR-17~92 was sufficient to induce cardiomyocyte proliferation in adult hearts 
and was associated with enhanced cardiac function following myocardial 
infarction (74). miR-17~92 appears to exert its biological actions through 
regulation of the phosphatase and tensin homolog (PTEN), an important 
regulator of phosphoinositide 3-kinase (PI3K) signaling. Although further studies 
are required to determine whether miR-17~92 plays any role during endogenous 
regeneration of the neonatal heart, these findings suggest that activation of this 
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miRNA cluster may represent a potentially important strategy towards induction 
of cardiomyocyte proliferation and cardiac regeneration in adults. 
 
A recent study by Eulalio et al. has identified dozens of additional miRNAs with 
previously unknown roles in cardiomyocyte proliferation (75). In this study, 
cardiomyocytes were systematically screened against a library of 875 miRNA 
mimics to identify potential candidates capable of inducing cardiomyocyte 
proliferation. As two of the most potent inducers of cardiomyocyte proliferation, 
miR-199a and miR-590 were selected for further follow-up studies. In a powerful 
demonstration of the utility of functional genomic screens, over-expression of 
miR-199a and miR-590, respectively, was sufficient for induction of 
cardiomyocyte proliferation in vivo in neonatal and adult mice. Moreover, over-
expression of these miRNAs was associated with increased cardiomyocyte 
proliferation rates, cardiac regeneration, reduced fibrotic scarring and improved 
cardiac function following myocardial infarction (75). A number of putative 
downstream target genes were identified for miR-199a and miR-590, including 
the Ca2+ signaling regulator Homer1, the homeodomain protein Hopx, and the 
chloride intracellular channel 5 (Clic5), all of which were demonstrated to inhibit 
cardiomyocyte proliferation (75). These findings further highlight the critical role 
of miRNAs during cardiomyocyte maturation and suggest that miRNAs may 
prove to be important drug targets for cardiac regeneration in the future. 
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5.3. Induction of cardiac regeneration through inhibition of Hippo signaling 
The Hippo signaling pathway has emerged as a major regulator of organ size in 
diverse species. The core signaling components of the Hippo pathway in 
mammals include the mammalian STE20-like protein kinase 1 and 2 (Mst1 and 
Mst2), the scaffolding protein Salvador (SAV), the large tumor suppressor 
homologue 1 and 2 (LATS1 and LATS2) protein kinases, Yes-associated protein 
(YAP) and the transcriptional co-activator with PDZ-binding motif (TAZ). 
Following activation of this signaling cascade, the transcriptional co-activators 
Yap and Taz become phosphorylated, which results in their exclusion from the 
nucleus and disrupts their association with DNA binding transcription factors that 
normally drive cellular growth. In the heart, genetic deletion of Salvador during 
embryonic development in the mouse is associated with massively overgrown 
hearts and elevated cardiomyocyte proliferation indices (76). Ablation of Mst1/2 
or Lats2 causes a similar embryonic cardiac phenotype (76). Interestingly, 
Salvador deletion was associated with the up-regulation of a number of Wnt 
target genes and an increase in nuclear -catenin, suggesting that there is 
considerable cross-talk between the Hippo and canonical Wnt/-catenin 
signaling pathways. Indeed, reducing the levels of -catenin rescues the 
cardiomyocyte proliferation phenotype in Salvador knockout mice (76).  
 
Recent studies have also established that the transcriptional co-activator Yap is 
both necessary and sufficient to drive cardiomyocyte proliferation during 
embryogenesis and neonatal heart regeneration. Genetic loss-of-function studies 
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have revealed that Yap is required for cardiomyocyte proliferation during 
embryonic heart development (77-79). Deletion of Yap in the embryonic mouse 
heart causes myocardial hypoplasia and early embryonic lethality (77, 79). 
Similarly, deletion of Yap in the postnatal heart results in a progressive dilated 
cardiomyopathy and is associated with a reduced number of mitotic 
cardiomyocytes during the neonatal period (78). Following neonatal myocardial 
infarction, Yap cardiac-knockout mice fail to mount a regenerative response and 
instead are characterized by cardiac fibrosis and cardiac dilation, reminiscent of 
pathological cardiac remodeling in adult mice (78). Conversely, over-expression 
of a constitutively active form of Yap in the embryonic heart increases 
cardiomyocyte number and heart size (79). Over-expression of constitutively 
active Yap in cultured neonatal cardiomyocytes in vitro was also associated with 
induction of cardiomyocyte proliferation and this effect operates through 
activation of the IGF signaling pathway and downstream inactivation of GSK3. 
Moreover, transgenic over-expression of constitutively active Yap in postnatal 
cardiomyocytes is sufficient to drive cardiomyocyte proliferation, reduce fibrosis 
and improve cardiac function following myocardial infarction in adult mice (78). 
Similar results were also reported in cardiomyocyte-specific Salvador knockout 
mice, which demonstrated an enhanced regenerative response and diminished 
fibrotic response to either apical resection injury or myocardial infarction at post-
natal day 8 (80). These findings demonstrate that the Hippo signaling pathway is 
a critical regulator of cardiomyocyte proliferation and cardiac regeneration in 
mammals. 
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5.4. Meis1 defines a transcriptional hierarchy for cardiomyocyte 
proliferation 
In contrast to the transcriptional networks that govern early embryonic heart 
development, little is known about the transcriptional regulation of postnatal 
cardiomyocyte maturation. To this end, a recent study by Mahmoud et al. 
identified a novel role for the transcription factor Meis1 during postnatal 
cardiomyocyte cell cycle arrest (81). Meis1 belongs to the TALE (three amino 
acid loop extension) family of homeodomain transcription factors and was 
previously shown to play an important role during embryonic hematopoiesis and 
heart development (82, 83). Recent genome-wide epigenetic mapping studies 
have revealed important functions for Meis transcription factors during cardiac 
differentiation (84, 85). These studies have shown that Meis transcription factors 
act independently, as well as in concert with other important cardiac transcription 
factors such as Gata4, to regulate a plethora of genes with important roles in 
cardiac development (84, 85). However, the functions of Meis transcription 
factors in the post-natal heart have only recently begun to be elucidated. 
Constitutive deletion of Meis1 in the postnatal mouse heart was associated with 
an increased incidence of cardiomyocyte proliferation (81). Importantly, 
conditional deletion of Meis1 in the adult heart was sufficient to induce 
cardiomyocyte cell cycle re-entry in a subset of adult cardiomyocytes. PCR 
arrays and transcriptional assays subsequently revealed that Meis1 was required 
for transcriptional activation of the synergistic cyclin-dependent kinase (CDK) 
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inhibitors p15, p16 and p21, thus identifying Meis1 as an important upstream 
component of the transcriptional hierarchy that governs cardiomyocyte cell cycle 
arrest after birth (81). 
 
In order to determine the role of Meis1 during neonatal heart regeneration, 
inducible transgenic mice were subjected to myocardial infarction at P1. In 
contrast to wild-type mice, Meis1 over-expression in the neonatal heart reduced 
the number of mitotic cardiomyocytes following injury and was associated with a 
much more limited regenerative response characterized by increased fibrotic 
scarring and cardiac contractile dysfunction (81). Therefore, similar to miR-195 
over-expression or Yap deletion, Meis1 over-expression is sufficient to impair the 
neonatal cardiac regenerative response through inhibition of cardiomyocyte 
proliferation (Figure 3). 
 
6. Endogenous cardiac stem and progenitor cells 
Resident tissue stem and progenitor cell populations reside in most adult tissues 
and contribute to cellular homeostasis and repair throughout life. In the heart, 
several cardiac stem/progenitor populations have been identified at different 
developmental stages including the embryonic, neonatal and adult heart. Cardiac 
stem cells have been identified on the basis of cell surface marker expression 
(e.g. c-kit, Sca-1), transcription factor expression (e.g. Isl-1), physiological dye 
efflux properties and propensity to form multicellular clusters (e.g. cardiospheres, 
colony-forming units-fibroblasts (cfu-f)) (9, 86-90). Given that mammalian 
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cardiomyocyte renewal is extremely limited in the adult heart following infarction, 
it is important to determine whether cardiac stem cells might play an important 
role in more highly regenerative organisms, such as zebrafish and neonatal mice.  
 
6.1. Epicardial progenitors in the regenerating heart 
The epicardium is a single mesothelial layer of cells that envelops the heart. 
Genetic lineage tracing studies in the mouse using Cre-loxP technology have 
identified the epicardium as a reservoir of multipotent cardiac progenitor cells that 
provide an important source of fibroblasts, vascular smooth muscle cells, 
perivascular cells and cardiomyocytes during embryogenesis (91-93). Thus, the 
role of epicardial cells during cardiac regeneration has also attracted significant 
interest. However, lineage-tracing studies in adult mice have so far failed to 
identify a major contribution of the epicardial lineage to cardiomyogenesis 
following myocardial infarction in adult mice or following cardiac injury in adult 
zebrafish (94, 95).  
 
Epicardial genes are rapidly activated in an organ-wide manner in adult zebrafish 
and neonatal mice following cardiac injury (32, 50). In zebrafish, the epicardium 
provides an important source of growth factors such as RA and Pdgf, which 
support cardiomyocyte proliferation and cardiac regeneration (Figure 2) (49, 96). 
In addition, Kikuchi et al. and Gonzales-Rosa et al. traced the descendants of the 
tcf21+ epicardial lineage and identified myofibroblasts and perivascular cells 
derived from this cell source following apical resection or cryoinjury, respectively 
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(94, 97). Neither study identified any cardiomyocytes derived from the epicardial 
lineage during cardiac regeneration. However, the vascular and cardiomyogenic 
potential of epicardial cells could potentially be enhanced in the adult heart 
following injury by treatment with specific growth factors. For example, the 
peptide thymosin 4 has been shown to enhance the vascular and 
cardiomyogenic potential of epicardial progenitor cells in vivo following 
myocardial infarction (98, 99). It will be important in the future to determine the 
relative contribution of epicardial progenitors to different cardiac lineages during 
neonatal mammalian heart regeneration in order to identify any potential 
developmental mechanisms that could be exploited to enable cardiac 
regeneration in adults. 
 
6.2. c-kit progenitor cells and neonatal heart regeneration 
To determine whether c-kit+ cells are capable of supporting regeneration of the 
neonatal heart, Jesty et al. subjected neonatal and adult c-kit-EGFP reporter 
mice to cryoinjury (38). Cardiac injury in neonatal mice was associated with 
robust activation of c-kit around the site of injury but not in remote regions. 
Interestingly, a substantial proportion of c-kit+ cells were of a cardiac phenotype 
at day 3 (67%) and day 7 (88%) following cryoinfarction (38). The majority of the 
remaining c-kit+ cells were endothelial cells. In vivo pulse-labeling with BrdU also 
identified a substantial proportion of proliferating cardiomyocytes in the 
regenerating neonatal heart that were positive for c-kit (42% at day 5 post-
cryoinfarction) (38). In contrast, adult c-kit+ cells adopted a vascular fate 
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following cryoinfarction and did not contribute to cardiomyocyte formation, a 
finding that contradicts other reports of a robust cardiomyogenic potential for this 
stem cell population in adults (9, 100). While this study supports the notion of a 
differential regenerative capacity of the neonatal and adult heart, which may be in 
part accounted for by physiological alterations in the properties of c-kit+ cells, 
some caveats warrant further investigation. In particular, precise lineage tracing 
studies and ablation of the c-kit+ cell population in neonatal mice, as reported 
recently for this cell population in an adult isoproterenol-induced heart failure 
model (101), will be required to fully establish the contribution of this stem cell 
population to neonatal heart regeneration. Furthermore, given that c-kit is 
expressed by differentiated cardiomyocytes (102), de-differentiating 
cardiomyocytes (103, 104) and mast cells (105), the relative activity of this 
reporter construct in these different cell populations will need to be ascertained in 
order to perform controlled genetic fate mapping studies. It will also be interesting 
to determine whether cardiac stem cells exert paracrine effects that support heart 
regeneration during early developmental stages in mammals.    
 
7. Angiogenic and vasculogenic responses during heart regeneration 
Re-establishment of a new vasculature following cardiac injury is vital for heart 
regeneration. In neonatal mice, large epicardial blood vessels are evident in the 
regenerated heart following apical resection injury (32). Recent studies also 
indicate that cardiac regeneration following neonatal myocardial infarction is 
associated with a robust vasculogenic response with large collateral vessels 
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penetrating the infarcted territory during regeneration (36). In contrast, a similar 
vascular injury response is not evident in adult rodents, suggesting that important 
developmental differences in the reparative potential of vascular cells may 
contribute to the loss of cardiac regenerative capacity during the neonatal period. 
 
Two of the most important pro-angiogenic factors during zebrafish heart 
regeneration are Fgf and Pdgf (Figure 2). Following apical resection injury, Fgf 
ligands, such as fgf17b, are up-regulated in the myocardium, while the Fgf 
receptors fgfr2 and fgfr4 are induced in epicardial cells (50). Transgenic loss-of-
function studies in the zebrafish have established that Fgf receptor expression in 
epicardial cells is required for epicardial cell invasion into the wound site and 
neovascularization. In the absence of Fgf receptor-dependent 
neovascularization, the zebrafish heart fails to regenerate following injury and 
forms a large fibrotic scar (50). Similarly, Pdgf signaling is also required for 
epicardial cell proliferation and blood vessel formation following cardiac injury in 
zebrafish. The PDGF receptor alpha (pdgfr) gene is up-regulated in epicardial 
cells and at the wound site following apical resection injury, while the PDGF-B 
ligand is expressed locally in the wound site by CD41-positive thrombocytes (96, 
106). Pharmacological inhibition of Pdgf signaling inhibits neovascularization 
following apical resection injury (96). These findings have established an 
important myo-epicardial growth factor signaling nexus during cardiac 
regeneration and it will be important to establish whether these signaling 
pathways are also activated during neonatal heart regeneration in mammals. 
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Given the exciting recent developments in modified RNA-based delivery methods 
for angiogenic growth factors, such as vascular endothelial growth factor (VEGF) 
(107), it may be possible to recapitulate some of these pro-regenerative and pro-
angiogenic signaling pathways in the adult heart in the future. 
 
8. The extracellular matrix facilitates cardiac regeneration 
The predominant reparative response to cardiac injury in adult mammals involves 
the replacement of damaged myocardial tissue with a permanent collagenous 
scar. Cardiac fibroblasts account for up to two thirds of all cardiac cells and are 
embedded within the extracellular matrix (ECM) where they secrete the collagens 
required for matrix synthesis, as well as growth factors that support 
cardiomyocyte function and remodeling (108). In contrast to the fibrotic response 
of the adult heart following infarction, the neonatal heart does not form a stable 
fibrotic scar. However, there is considerable ECM deposition during the first week 
following cardiac injury in neonatal mice (32, 36). Subsequently, the fibrotic 
tissue becomes marginalized to the periphery and regresses over several weeks 
before being almost completely replaced with regenerated cardiomyocytes (36). 
In the absence of an adequate myocyte proliferative response in the neonate, the 
default repair response is characterized by the presence of a fibrotic scar (36, 78, 
81). These findings suggest that there is a reciprocal relationship between 
cardiomyocyte proliferation and fibrosis. Although little is known about the 
communication between fibroblasts and cardiomyocytes at early developmental 
stages, there is some evidence that cardiac fibroblasts regulate myocardial 
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proliferation during embryogenesis. For example, fibronectin, collagen and 
heparin-binding EGF-like growth factor are all produced by embryonic cardiac 
fibroblasts and can promote proliferation of immature cardiomyocytes (109). 
These proliferative effects are dependent on the expression of the ECM receptor, 
1 integrin, in cardiomycytes. Interestingly, the expression of different integrin 
subunits (e.g. Itga1, Itgb1, Itga6 and Itga7), which have varying propensities to 
bind to different ECM components (e.g. collagen, laminin, fibronectin), changes 
during cardiomyocyte maturation (109). It is therefore possible that postnatal 
changes in the ECM contribute to cardiomyocyte cell cycle withdrawal during the 
neonatal period. Furthermore, as re-establishment of the ECM is important for 
heart regeneration, further studies will be required in order to determine whether 
ECM components provide integral signals for neonatal heart regeneration. 
 
Results from several recent studies in lower vertebrates are consistent with an 
important role for ECM-derived signals for heart regeneration (Figure 2). 
Fibronectin, a major component of the ECM, is secreted by epicardial cells and 
deposited at the injury site after cardiac injury in zebrafish (110). Loss-of-function 
experiments established that fibronectin is required for cardiac regeneration in 
zebrafish, although it does not affect cardiomyocyte proliferation in this species 
(110). The mechanism by which ECM-derived fibronectin influences heart 
regeneration in zebrafish is currently unknown but could be due to a potential 
role of fibronectin signaling on cardiomyocyte migration or epicardial cell function. 
On the other hand, transforming growth factor beta (TGF) ligands and receptors 
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(tgfbr1b) are induced in fibroblasts and cardiomyocytes following cryoinjury in 
zebrafish and are required for cardiac regeneration (111). Transient scar 
formation was found to be an essential step in the zebrafish regenerative 
response following cryoinjury and pharmacological inhibition of TGF signaling 
abolished the regenerative response (111). Thus, early ECM deposition and 
TGF-mediated cardiomyocyte proliferative signals are required for zebrafish 
heart regeneration. Furthermore, a recent study in adult newts has established 
that early up-regulation of ECM components in the epicardium precedes 
cardiomyocyte proliferation and migration in this species. Interestingly, the ECM-
derived component tenascin-C was shown to be sufficient to induce 
cardiomyocyte proliferation in vitro, suggesting that ECM-derived signals in the 
adult newt are also required for induction of cardiomyocyte proliferation during 
cardiac regeneration (112).  
 
9. Do neonatal immune responses dictate cardiac regenerative outcomes? 
Cardiac injury in lower vertebrates, neonatal mice and adult mammals is 
associated with inflammation, yet the physiological consequences of injury in 
neonatal and adult mammals are vastly different. The immune response is 
important for clearing cellular debris following myocardial infarction in adults but it 
also facilitates scar formation, which ultimately compromises cardiac function 
(113). Indeed, multiple lines of evidence support the notion that the adult 
mammalian immune system constrains regenerative capacity and recent studies 
suggest that the immune response to injury supports regeneration in lower 
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vertebrates (114-116). In mammals, the adaptive and innate immune systems 
undergo drastic alterations and maturation during the neonatal period, coinciding 
with the developmental loss of cardiac regenerative capacity (117-120).  
 
A recent study by Aurora et al. suggests that these postnatal changes in the 
immune system may also play an important role in dictating regeneration versus 
repair responses of the neonatal heart following injury (121). Through systematic 
profiling of the cellular immune response to cardiac injury, Aurora et al. identified 
a number of qualitative and quantitative differences in the cellular immune 
response of 1-day-old (regenerative) and 14-day-old (non-regenerative) mice 
following myocardial infarction. Differences in the monocyte and macrophage 
responses to cardiac injury in neonatal mice were particularly prevalent. 
Subsequent depletion of macrophages in neonatal mice using a clodronate-
liposome depletion method revealed that macrophages are required for neonatal 
heart regeneration following myocardial infarction. In contrast to the pro-fibrotic 
role of macrophages in the adult heart, neonatal macrophages were found to be 
required for heart regeneration. Interestingly, macrophages did not influence 
cardiomyocyte proliferation following infarction but were essential for 
angiogenesis (Figure 3). Molecular profiling of macrophages in the regenerating 
(P1) and non-regenerating (P14) heart following infarction revealed a unique 
transcriptional signature of neonatal macrophages, including the expression of 
several potentially important pro-angiogenic cytokines. Future studies will be 
required to uncover the underlying mechanisms that govern these 
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developmentally distinct macrophage responses to injury. In addition, whether 
the absence of regeneration in adult mammals is due to differences in the types 
of inflammatory cells that are recruited, the specific signals secreted from 
inflammatory cells, or the responsiveness of different cardiac cell types to these 
inflammatory stimuli remains to be determined. 
 
10. Conclusions and future perspectives 
It has been suggested that developmental mechanisms are prisoners of their 
own phylogenetic histories (122). On the basis of recent studies of cardiac 
regeneration in fetal/neonatal mammals, it would appear that regenerative 
mechanisms are also prisoners of their developmental histories. These findings 
raise the following question - what is the evolutionary advantage of shutting down 
cardiac regenerative pathways after birth? It appears that in the absence of any 
selective pressure to maintain regenerative capacity in organisms that typically 
don’t succumb to cardiovascular disease until well after reproductive maturity, 
there may not have been a strong evolutionary drive to maintain regenerative 
potential after birth in mammals. So, what could be the advantage of arresting 
cardiomyocyte proliferation after birth? In mammals, the heart undergoes a 
number of physiological adaptations during the immediate postnatal period to 
cope with the increased loading and oxygen demands associated with the 
pulmonary circulation, and the rapid growth demands of postnatal life (123). 
These environmental and physiological stressors are matched by marked 
structural and metabolic adaptations in the cardiomyocyte, including a switch 
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from glycolyis to fatty acid oxidation and sarcomere reorganization, both of which 
are suited to the high-energy demands of the postnatal heart (124). Given the 
requirement to disassemble sarcomeres during cell division (125), cardiomyocyte 
proliferation may not be particularly advantageous during postnatal life in 
mammals and this adaptation may have come at the expense of cardiac 
regeneration. An important aspect of future studies that attempt to recapitulate 
early developmental regenerative mechanisms, including cardiomyocyte cell 
cycle re-entry, will be to establish whether these approaches have any 
detrimental effects on adult cardiac physiology. It is our belief that understanding 
the detailed physiological and molecular mechanisms that drive cardiomyocyte 
maturation and regenerative arrest during neonatal life will be imperative for 
establishing the biological basis and clinical utility of future cardiac regenerative 
therapies. 
 
Much work remains to be done in order to identify the molecular and cellular 
basis for neonatal heart regeneration. However, recent studies suggest that re-
activation of neonatal cardiac regenerative pathways to drive cardiomyocyte 
proliferation in the adult heart may be possible (36, 78, 81). Given the ever-
expanding molecular genetic and pharmacological toolkit for studies in mammals 
and lower vertebrates, it is likely that many more natural cardiac regenerative 
mechanisms will be identified in the near future. If successful, these studies may 
indeed uncover a developmental blueprint for cardiac regeneration. 
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Figure Legends: 
Figure 1: Different injury models for studies of cardiac regeneration in the newt, 
zebrafish and neonatal mouse. Cardiomyocyte proliferative responses (localized 
or global) and the outcomes of genetic lineage tracing experiments are 
highlighted. Green dots denote proliferating cardiomyocytes. 
 
Figure 2: Molecular and cellular mechanisms of cardiac regeneration in adult 
zebrafish. Retinoic acid (RA) is produced and released by epicardial and 
endocardial cells shortly after injury and acts on cardiomyocytes to induce 
proliferation. Other proliferative cues are also received from non-myocyte 
populations such as fibroblasts, which generate several important pro-
regenerative extracellular matrix components such as transforming growth factor 
 (TGF), tenascin-C and fibronectin. Platelet-derived growth factor BB isoform 
(PDGF-BB) and fibroblast growth factor (FGF) are produced by thrombocytes 
and myocardial cells, respectively, and act on their cognate receptors (PDGFR 
and FGFR) in the epicardium to promote angiogenesis.  
 
Figure 3: Molecular and cellular mechanisms of cardiac regeneration in neonatal 
mice. Cardiomyocyte proliferation and angiogenesis are both required for 
complete regeneration of the neonatal heart following injury. Cardiomyocyte 
proliferation in the neonatal heart is activated by Yap and restricted by the miR-
15 family and Meis1. Macrophages are also recruited to the injury site where they 
promote angiogenesis. 
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Highlights: 
 
 Neonatal mice regenerate following cardiac injury. 
 
 Neonatal heart regeneration occurs through cardiomyocyte proliferation. 
 
 Cardiomyocyte proliferation is regulated by the miR-15 family, Yap and 
Meis1. 
 
 Macrophages are required for neonatal heart regeneration. 
